A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease

Infection

Volumn 43, Issue 3, 2015, Pages 353-359

  Taniguchi, Rumi ^a,b   Koyano, Shin ^c   Suzutani, Tatsuo ^d   Goishi, Keiji ^b,e   Ito, Yushi ^e   Morioka, Ichiro ^f   Nakamura, Hiroyuki ^e   Yamada, Hideto ^f   Oka, Akira ^b   Inoue, Naoki ^a,g  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f KOBE UNIVERSITY   (Japan)

^g GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Congenital cytomegalovirus disease; Natural killer cell; NKG2D; Single nucleotide polymorphism

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED CHAIN A; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ALLELE; ARTICLE; CONGENITAL CYTOMEGALOVIRUS INFECTION; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION; GENETICS; INFANT; MALE; MISSENSE MUTATION; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION, MISSENSE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84930272712     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0774-x     Document Type: Article

References (10)

1. Koyano S, Inoue N, Oka A, et al. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open. 2011; 1:e000118.
2. Taniguchi R, Koyano S, Suzutani T, et al. Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis. 2013;17:e1092–7.
3. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008;9:495–502.
4. Chalupny NJ, Rein-Weston A, Dosch S, et al. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun. 2006;346:175–81.
5. Zhang Y, Lazaro AM, Lavingia B, Stastny P. Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol. 2001;62:620–31.
6. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727–9.
7. Tong HV, Toan NL, Song LH, et al. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants. J Viral Hepat. 2013;20:687–98.
8. Brown BK, Wieczorek L, Kijak G, et al. The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. PLoS One. 2012;7:e29454.
9. Tumurkhuu M, Saitoh M, Takita J, et al. A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways. J Recept Signal Transduct Res. 2013;33:124–8.
10. Garrity D, Call ME, Feng J, Wucherpfenning KW. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci. 2005;102:7641–6.